Tuesday, April 21

11:00 a.m. – 11:45 a.m.           Welcome, AATB Updates and Q & A

                                                Diana Buck, MEd, MBA, CTBS, Sr. VP, Tissue Donation Services, New England Donor Services and Chair, AATB Board of Governors

11:45 a.m. – 12:30 p.m.           BUILDING AND MAINTAINING A HEALTHY TISSUE RECOVERY PROGRAM

                                                Shannon Renaud, CTBS, Tissue Procurement Trainer, Gift of Life Michigan

                                                Emmitt Savannah, III, CTBS, Tissue Technical Training Supervisor, LifeGift

12:30 – 1:00 p.m.                    BREAK

1:00 p.m. – 1:45 p.m.             UNDERSTANDING REGULATORY NOMENCLATURE

                                             Mark Durivage, Contract Inspector, AATB

1:45 p.m. – 2:30 p.m.               USING AUTOMATED QUALITY ASSURANCE FOR TISSUE REFERRALS

                                                 Ann Venezia, Business & Data Analyst, Gift of Hope

Thursday, April 23

 11:00 a.m. – 11:15 a.m.            WELCOME FROM THE AATB PROGRAM COMMITTEE

                                                Rhiannon Kneuven, BS, CTBS, Tissue Services Manager, Donor Network of Arizona and Co-Chair, AATB Program Committee

                                                Kim Elliott, VRL Eurofins and Co-Chair, AATB Program Committee

11:15 a.m. – 12:00 p.m.             ELIGIBILITY VS. SUITABILITY

                                                  Terri Wedding, CTBS, Quality Assurance Manager, LifeNet Health

12:00 p.m. – 12:30 p.m.            BREAK

12:30 p.m. – 1:15 p.m.               PERFORMANCE IMPROVEMENT IN OPOs AS IT RELATES TO TISSUE

                                                  Linda Martin, CTBS, VP, Tissue and Support Services, Mid-America Transplant

1:15 p.m. – 2:00 p.m.               CALCULATING THE COST OF QUALITY

                                                Jennifer Wesbrook, CTBS, Director of Quality, Essent Biologics

2:00 p.m. - 3:30 p.m.                COVID-19 Updates and Key Considerations

                                                   Roman Hitchev, MD, MPH, VP and Chief Science Officer, AATB